TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
TSRX was delisted on the 11th of September, 2013.
1 hedge funds and large institutions have $54K invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 6 closing their positions.
86% less funds holding
Funds holding: 7 → 1 (-6)
90% less capital invested
Capital invested by funds: $529K → $54K (-$475K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$139K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$123K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$102K |
| 4 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
-$93K |
| 5 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$18K |
TSRX Hedge Fund Activity: Q4 2013 in Review
1 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q4 2013, worth a combined $54K — down 90% from $529K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of TSRX and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Panagora Asset Management, exiting entirely with an estimated $139K sold.
- 1 institutional investor held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q4 2013, down from 7 in Q3 2013.
- Funds reported $54K of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q4 2013, down 90% quarter-over-quarter.
- 0 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 6 closed out, a net change of -6 holders.
- The largest TRIUS THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was Panagora Asset Management, an estimated $139K sold.
Based on aggregated 13F filings for Q4 2013.